<DOC>
	<DOCNO>NCT02499679</DOCNO>
	<brief_summary>The objective HeartFlow ADVANCE Registry evaluate utility , clinical outcome resource utilization FFRCT-guided evaluation clinically stable , symptomatic patient coronary artery disease ( CAD ) order inform patient , health care provider , stakeholder technology effective efficient diagnosis management CAD .</brief_summary>
	<brief_title>Assessing Diagnostic Value Non-invasive FFRCT Coronary Care</brief_title>
	<detailed_description>REGISTRY OBJECTIVE The objective HeartFlow ADVANCE Registry evaluate utility , clinical outcome resource utilization FFRCT-guided evaluation clinically stable , symptomatic patient CAD order inform patient , health care provider , stakeholder technology effective efficient diagnosis management CAD . SPECIFIC OBJECTIVES : 1 . To determine availability FFRCT , addition coronary anatomy cCTA , lead significant change coronary management plan . 2 . To assess real world outcomes utilizing FFRCT guide invasive management and/or medical treatment . 3 . To assess resource utilization , follow standard practice diagnostic treatment pathway incorporate FFRCT preferred CAD diagnostic test . 4 . To provide society include patient , health care provider , stakeholder information diagnostic technology effective efficient manage patient CAD .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1 . Provide write informed consent 2 . Clinically stable , symptomatic patient undergo cCTA diagnose CAD meet eligibility criterion FFRCT . 1. cCTA show CAD 2 . Uninterpretable cCTA site assessment , severe artifact prevent angiographic evaluation 3 . Any active , serious , lifethreatening disease life expectancy le 1 year 4 . Inability comply followup requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>